{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:46:16Z","timestamp":1694821576855},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ejrad.2011.03.035","type":"journal-article","created":{"date-parts":[[2011,6,4]],"date-time":"2011-06-04T00:59:47Z","timestamp":1307149187000},"page":"1657-1661","source":"Crossref","is-referenced-by-count":1,"title":["Size and attenuation CT (SACT) of residual masses in patients with follicular Non-Hodgkin Lymphoma: More than a status quo?"],"prefix":"10.1016","volume":"81","author":[{"given":"Daniel","family":"Spira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichard","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"S\u00f6kler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"L\u00f6ffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejrad.2011.03.035_bib0005","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","article-title":"New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project","volume":"16","author":"Armitage","year":"1998","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejrad.2011.03.035_bib0010","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1470-2045(04)01490-1","article-title":"Non-Hodgkin lymphoma: an update","volume":"5","author":"Hennessy","year":"2004","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejrad.2011.03.035_bib0015","doi-asserted-by":"crossref","first-page":"W91","DOI":"10.2214\/AJR.09.2637","article-title":"Clinical utility of PET\/CT in lymphoma","volume":"194","author":"Cronin","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.ejrad.2011.03.035_bib0020","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.1988.6.6.931","article-title":"Residual mass in lymphoma may not be residual disease","volume":"6","author":"Canellos","year":"1988","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejrad.2011.03.035_bib0025","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1002\/1097-0142(19880615)61:12<2439::AID-CNCR2820611208>3.0.CO;2-Q","article-title":"Gallium 67 imaging in monitoring lymphoma response to treatment","volume":"61","author":"Israel","year":"1988","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejrad.2011.03.035_bib0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"issue":"2 Suppl.6","key":"10.1016\/j.ejrad.2011.03.035_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.32748","article-title":"Immunochemotherapy in indolent non-Hodgkin's lymphoma","volume":"29","author":"Czuczman","year":"2002","journal-title":"Semin Oncol"},{"issue":"5","key":"10.1016\/j.ejrad.2011.03.035_bib0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejrad.2011.03.035_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-004-0939-7","article-title":"Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology","volume":"84","author":"M\u00fcller","year":"2005","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.ejrad.2011.03.035_bib0050","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/cncr.10403","article-title":"Changing incidence of non-Hodgkin lymphomas in the United States","volume":"94","author":"Clarke","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejrad.2011.03.035_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics, 2000","volume":"50","author":"Greenlee","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejrad.2011.03.035_bib0060","volume":"vol. 2","year":"1998"},{"issue":"Suppl. 1","key":"10.1016\/j.ejrad.2011.03.035_bib0065","first-page":"19S","article-title":"Integrating PET and PET\/CT into the risk-adapted therapy of lymphoma","volume":"48","author":"Kasamon","year":"2007","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejrad.2011.03.035_bib0070","first-page":"522","article-title":"18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review","volume":"91","author":"Zijlstra","year":"2006","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.ejrad.2011.03.035_bib0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1200\/JCO.1985.3.5.637","article-title":"The significance of the residual mediastinal mass in treated Hodgkin's disease","volume":"3","author":"Jochelson","year":"1985","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejrad.2011.03.035_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1148\/radiol.2441060810","article-title":"Hodgkin disease: diagnostic value of FDG PET\/CT after first-line therapy\u2014is biopsy of FDG-avid lesions still needed?","volume":"244","author":"Schaefer","year":"2007","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ejrad.2011.03.035_bib0085","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2967\/jnumed.109.073197","article-title":"18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma","volume":"51","author":"Cerci","year":"2010","journal-title":"J Nucl Med"},{"issue":"32","key":"10.1016\/j.ejrad.2011.03.035_bib0090","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1200\/JCO.2008.17.2015","article-title":"Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma","volume":"26","author":"Morschhauser","year":"2008","journal-title":"J Clin Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejrad.2011.03.035_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1634\/theoncologist.2009-S2-4","article-title":"Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma","volume":"14","author":"Gregory","year":"2009","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ejrad.2011.03.035_bib0100","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1148\/radiology.219.3.r01jn06621","article-title":"Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment","volume":"219","author":"Rahmouni","year":"2001","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2011.03.035_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2214\/AJR.09.2941","article-title":"Assessing tumor response and detecting recurrence in metastatic renal cell carcinoma on targeted therapy: importance of size and attenuation on contrast-enhanced CT","volume":"194","author":"Smith","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"10.1016\/j.ejrad.2011.03.035_bib0110","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2214\/AJR.09.3456","article-title":"Morphology, attenuation, size, and structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy","volume":"194","author":"Smith","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"13","key":"10.1016\/j.ejrad.2011.03.035_bib0115","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X11003056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X11003056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T21:34:10Z","timestamp":1592602450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X11003056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0720048X11003056"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2011.03.035","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}